This study examines how a high false-positive rate in lung cancer screening influences the harm-to-benefit ratio for higher- vs lower-risk patients. Results from the Veterans Health Affairs (VHA) lung cancer screening (LCS) demonstration project.
This study examines how a high false-positive rate in lung cancer screening influences the harm-to-benefit ratio for higher- vs lower-risk patients. Results from the Veterans Health Affairs (VHA) lung cancer screening (LCS) demonstration project.